Table 7. Society of American Gastrointestinal and Endoscopic Surgeons - AHPBA Recommendations Regarding Surgical Management of HPB Cancer Patients During the Response to the COVID-19 Crisis (https://www.sages.org/sages-ahpba-recommendations-surgical-management-of- hpb-cancer-covid-19/).

Organ	Clinical Situation	Phase I	Phase II	Phase III
Liver	HCC  Very early stage (0)/Early Stage (A)/< 3 cm  * For later stages consider TACE, Medical therapy, supportive care as appropriate	Consider ablation/resection/trans- plant as appropriate	Consider TACE, ablation, or obser- vation (ie delay of definitive tx)
	Colorectal mets	Consider chemotherapy vs. resec- tion	Chemotherapy
Biliary	Intrahepatic cholangiocarcinoma	Consider chemotherapy vs. resec- tion	Consider chemotherapy, embolic therapy
	Hilar cholangiocarcinoma	Stenting as indicated.  Resection, transplantation as indi- cated	Stenting as indicated.  Consider chemotherapy, chemo- radiation, and/or transfer
Pancreatic and extra-hepatic biliary	Resectable	Resection or consider chemother- apy	Neoadjuvant chemotherapy
	Borderline	Neoadjuvant chemotherapy
	Pancreatic IPMN, cysts, low-mod grade neuroendocrine neoplasms	All: observation (i.e. delay surgical management) Neuroendocrine: if metastatic or progressing, consider targeted therapy